» Articles » PMID: 1747103

Determination of the Intracellular Sites and Topology of Glucosylceramide Synthesis in Rat Liver

Overview
Journal Biochem J
Specialty Biochemistry
Date 1991 Dec 1
PMID 1747103
Citations 80
Authors
Affiliations
Soon will be listed here.
Abstract

We examined the intracellular site(s) and topology of glucosylceramide (GlcCer) synthesis in subcellular fractions from rat liver, using radioactive and fluorescent ceramide analogues as precursors, and compared these results with those obtained in our recent study of sphingomyelin (SM) synthesis in rat liver [Futerman, Stieger, Hubbard & Pagano (1990) J. Biol. Chem. 265, 8650-8657]. In contrast with SM synthesis, which occurs principally at the cis/medial Golgi apparatus, GlcCer synthesis was more widely distributed, with substantial amounts of synthesis detected in a heavy (cis/medial) Golgi-apparatus subfraction, a light smooth-vesicle fraction that is almost devoid of an endoplasmic-reticulum marker enzyme (glucose-6-phosphatase), and a heavy vesicle fraction. Furthermore, no GlcCer synthesis was detected in an enriched plasma-membrane fraction after accounting for contamination by Golgi-apparatus membranes. These results suggest that a significant amount of GlcCer may be synthesized in a pre- or early Golgi-apparatus compartment. Unlike SM synthesis, which occurs at the luminal surface of the Golgi apparatus, GlcCer synthesis appeared to occur at the cytosolic surface of intracellular membranes, since (i) limited proteolytic digestion of intact Golgi-apparatus vesicles almost completely inhibited GlcCer synthesis, and (ii) the extent of UDP-glucose translocation into the Golgi apparatus was insufficient to account for the amount of GlcCer synthesis measured. These findings imply that, after its synthesis, GlcCer must undergo transbilayer movement to the luminal surface to account for the known topology of higher-order glycosphingolipids within the Golgi apparatus and plasma membrane.

Citing Articles

Niemann-Pick C-like Endolysosomal Dysfunction in DHDDS Patient Cells, a Congenital Disorder of Glycosylation, Can Be Treated with Miglustat.

Best H, Cook S, Waller-Evans H, Lloyd-Evans E Int J Mol Sci. 2025; 26(4).

PMID: 40003936 PMC: 11855410. DOI: 10.3390/ijms26041471.


Ceramide Metabolism Compartmentalized in the Endoplasmic Reticulum and Golgi Apparatus.

Futerman A Curr Top Membr. 2024; 40:93-110.

PMID: 39015509 PMC: 11250679. DOI: 10.1016/s0070-2161(08)60978-8.


Ceramides are fuel gauges on the drive to cardiometabolic disease.

Wilkerson J, Tatum S, Holland W, Summers S Physiol Rev. 2024; 104(3):1061-1119.

PMID: 38300524 PMC: 11381030. DOI: 10.1152/physrev.00008.2023.


Review of Eukaryote Cellular Membrane Lipid Composition, with Special Attention to the Fatty Acids.

Ali O, Szabo A Int J Mol Sci. 2023; 24(21).

PMID: 37958678 PMC: 10649022. DOI: 10.3390/ijms242115693.


Differential Regulation of Glucosylceramide Synthesis and Efflux by Golgi and Plasma Membrane Bound ABCC10.

Iqbal J, Al Otaibi A, Mubarak S, Alqarni A, Bakillah A Nutrients. 2023; 15(2).

PMID: 36678216 PMC: 9862172. DOI: 10.3390/nu15020346.


References
1.
BLIGH E, Dyer W . A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959; 37(8):911-7. DOI: 10.1139/o59-099. View

2.
Weinreb N, Brady R, Tappel A . The lysosomal localization of sphingolipid hydrolases. Biochim Biophys Acta. 1968; 159(1):141-6. DOI: 10.1016/0005-2744(68)90251-9. View

3.
Shukla G, RADIN N . Glucosyceramide synthase of mouse kidney: further characterization with an improved assay method. Arch Biochem Biophys. 1990; 283(2):372-8. DOI: 10.1016/0003-9861(90)90657-k. View

4.
Schwarzmann G, Sandhoff K . Metabolism and intracellular transport of glycosphingolipids. Biochemistry. 1990; 29(49):10865-71. DOI: 10.1021/bi00501a001. View

5.
Pagano R . Lipid traffic in eukaryotic cells: mechanisms for intracellular transport and organelle-specific enrichment of lipids. Curr Opin Cell Biol. 1990; 2(4):652-63. DOI: 10.1016/0955-0674(90)90107-p. View